Hyperhomocysteinemia and Changed Plasma Thiol Redox Status in Chronic Obstructive Pulmonary Disease
-
Anders Andersson
Abstract
Reduced and total homocysteine, cysteine, glutathione and cysteinylglycine in plasma were investigated in 19 patients with chronic obstructive pulmonary disease and in 29 healthy subjects. The purpose was to examine the influence of pro-oxidant activity caused by the lung disease on the metabolism of homocysteine and other plasma thiols. We observed a decreased concentration of reduced glutathione and a decreased ratio of reduced/total glutathione in the patients compared to the healthy individuals, which supports the hypothesis of an association between free radicals and pathogenesis in some lung diseases. We also observed an increased total plasma homocysteine. The influence of a possible extracellular pro-oxidant activity on the concentration of total plasma homocysteine is discussed.
Copyright © 2001 by Walter de Gruyter GmbH & Co. KG
Articles in the same Issue
- Autoantibodies Associated with Rheumatic Diseases
- Simultaneous Detection of Multiple Proteins with an Array-Based Enzyme-Linked Immunosorbent Assay (ELISA) and Enhanced Chemiluminescence (ECL)
- Hippuric Acid Test Using 13C-Labelling and NMR Spectroscopy
- Hippuric Acid as a Modifier of Calcium Oxalate Crystallisation
- Excretion of Sweat and Urine Pyridinoline Crosslinks in Healthy Controls and Subjects with Established Metabolic Bone Disease
- Hyperhomocysteinemia and Changed Plasma Thiol Redox Status in Chronic Obstructive Pulmonary Disease
- Biochemical Evaluation of Oxidative Stress during Exercise in Patients with Coronary Heart Disease
- Prognostic Significance of the Presence of Erythroblasts in Blood after Cardiothoracic Surgery
- Exploratory Biochemical Data Analysis: a Comparison of Two Sample Means and Diagnostic Displays
- Standardization of Laboratory Data and Establishment of Reference Intervals in the Fukuoka Prefecture: A Japanese Perspective
- Calibration, Specificity and Trueness of a Postheparin Plasma Lipoprotein Lipase Assay
- Analytical Performance of a Direct Assay for LDL-Cholesterol
- Genotyping Method for Point Mutation Detection in the Endothelial Nitric Oxide Synthase Exon 7 Using Fluorescent Probes. Clinical Validation in Systemic Sclerosis Patients
- IFCC Reference Measurement Procedure for Substance Concentration Determination of Total Carbon Dioxide in Blood, Plasma or Serum
- Joshua Lederberg (Editor-in-Chief): Encyclopedia of Microbiology, 2nd Edition, Vol 1-4
Articles in the same Issue
- Autoantibodies Associated with Rheumatic Diseases
- Simultaneous Detection of Multiple Proteins with an Array-Based Enzyme-Linked Immunosorbent Assay (ELISA) and Enhanced Chemiluminescence (ECL)
- Hippuric Acid Test Using 13C-Labelling and NMR Spectroscopy
- Hippuric Acid as a Modifier of Calcium Oxalate Crystallisation
- Excretion of Sweat and Urine Pyridinoline Crosslinks in Healthy Controls and Subjects with Established Metabolic Bone Disease
- Hyperhomocysteinemia and Changed Plasma Thiol Redox Status in Chronic Obstructive Pulmonary Disease
- Biochemical Evaluation of Oxidative Stress during Exercise in Patients with Coronary Heart Disease
- Prognostic Significance of the Presence of Erythroblasts in Blood after Cardiothoracic Surgery
- Exploratory Biochemical Data Analysis: a Comparison of Two Sample Means and Diagnostic Displays
- Standardization of Laboratory Data and Establishment of Reference Intervals in the Fukuoka Prefecture: A Japanese Perspective
- Calibration, Specificity and Trueness of a Postheparin Plasma Lipoprotein Lipase Assay
- Analytical Performance of a Direct Assay for LDL-Cholesterol
- Genotyping Method for Point Mutation Detection in the Endothelial Nitric Oxide Synthase Exon 7 Using Fluorescent Probes. Clinical Validation in Systemic Sclerosis Patients
- IFCC Reference Measurement Procedure for Substance Concentration Determination of Total Carbon Dioxide in Blood, Plasma or Serum
- Joshua Lederberg (Editor-in-Chief): Encyclopedia of Microbiology, 2nd Edition, Vol 1-4